• Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • EA Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Stay Updated
  • We’re hiring!
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • EA Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Stay Updated
  • We’re hiring!

Stanford University — Universal Flu Drug Research (Jeffrey Glenn)

Visit Grantee Site
  • Focus Area: Scientific Research
  • Organization Name: Stanford University
  • Amount: $415,000

  • Award Date: July 2020

Table of Contents


    Grant investigators: Heather Youngs and Chris Somerville

    This page was reviewed but not written by the grant investigators. Stanford University staff also reviewed this page prior to publication.


    Open Philanthropy recommended a grant of $415,000 to Stanford University to support work led by Professor Jeffrey Glenn to test the efficacy of a universal antiviral drug candidate against all influenza strains. An effective pan-influenza antiviral drug could avert hundreds of thousands of deaths annually and minimize the spread of highly infectious and lethal strains of the virus. Professor Glenn intends to use this funding to conduct protective assays in ferrets, a transmission study, and a pharmacokinetics and distribution analysis.

    This follows our June 2020 support and falls within our work on scientific research, specifically within our interest in science supporting biosecurity and pandemic preparedness.

    Related Items

    • Scientific Research

      Stanford University — Research on Science and Innovation (Heidi Williams)

      Open Philanthropy recommended a grant of $600,823 to Stanford University to support a one-year period of research leave for Professor Heidi Williams. During this time, Professor Williams will pursue research...

      Read more
    • Scientific Research

      Stanford University — Research on Lipid Nanoparticles (Jeffrey Glenn)

      Open Philanthropy recommended a grant of $610,000 over two years to Stanford University to support a collaboration between Professor Jeffrey Glenn and Professor James Dahlman, of Georgia Tech,...

      Read more
    • Scientific Research

      Stanford University — Coronavirus Drug Research (June 2020) (Jeffrey Glenn)

      Open Philanthropy recommended a grant of $2,531,000 over three years to Stanford University to support work led by Professor Jeffrey Glenn to test an antiviral drug candidate against...

      Read more
    Back to Grants Database
    Open Philanthropy
    Open Philanthropy
    • Careers
    • Press Kit
    • Governance
    • Privacy Policy
    Mailing Address
    182 Howard Street #225
    San Francisco, CA 94105
    Email
    [email protected]
    Media Inquiries
    [email protected]
    Anonymous Feedback
    Feedback Form

    Sign Up to Follow Our Work

    Join Our Mailing List

    © Open Philanthropy 2022